Koji Nagafuji Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

2/2024	Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma.
11/2023	Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
10/2023	Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide.
12/2022	Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis.
1/2022	Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation.
11/2019	Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation.
2/2018	Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan.
1/2018	Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.
1/2017	Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.
4/2016	Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Nagafuji Research Topics

Disease

18	Neoplasms (Cancer) 02/2024 - 05/2003
17	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 12/2004
16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 01/2005
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 10/2006
10	Lymphoma (Lymphomas) 02/2024 - 04/2003
8	Multiple Myeloma 03/2024 - 10/2010
8	Leukemia 11/2022 - 12/2006
7	Infections 01/2024 - 11/2003
7	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2021 - 08/2010
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 12/2004
5	Disease Progression 03/2024 - 11/2018
5	Bronchiolitis Obliterans Syndrome 01/2024 - 11/2003
5	Hematologic Neoplasms (Hematological Malignancy) 06/2023 - 06/2012
5	Philadelphia Chromosome 01/2023 - 02/2013
4	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 10/2007
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2016 - 02/2004
3	Aplastic Anemia (Anemia, Hypoplastic) 12/2023 - 04/2013
3	Fever (Fevers) 10/2022 - 11/2012
3	Acute Promyelocytic Leukemia 01/2022 - 09/2020
3	Anemia 02/2021 - 01/2007
3	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 05/2011
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2016 - 01/2006
3	Cytomegalovirus Infections (Inclusion Disease) 07/2012 - 04/2007
2	Fibrosis (Cirrhosis) 12/2024 - 10/2022
2	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 04/2003
2	Hematoma 01/2024 - 12/2004
2	Hemorrhage 01/2024 - 01/2007
2	Monoclonal Gammopathy of Undetermined Significance 02/2023 - 04/2016
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2023 - 01/2019
2	Pathologic Complete Response 01/2023 - 10/2006
2	Edema (Dropsy) 10/2022 - 06/2004
2	Thrombocytopenia (Thrombopenia) 10/2022 - 10/2010
2	COVID-19 01/2022 - 01/2022
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 06/2020
2	Neutropenia 01/2021 - 07/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2019 - 06/2009
2	Residual Neoplasm 12/2019 - 09/2019
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2018 - 01/2018
2	T-Cell Lymphoma (Lymphoma, T Cell) 04/2017 - 01/2010
2	Mycoses (Diseases, Fungus) 03/2013 - 03/2010
2	Hemorrhagic Cystitis 08/2012 - 03/2012
2	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2011 - 05/2011
2	Aspergillosis 07/2011 - 03/2010
2	Pain (Aches) 11/2010 - 10/2006
2	Heart Failure 04/2007 - 11/2003
1	Extranodal NK-T-Cell Lymphoma 02/2024
1	Virus Diseases (Viral Diseases) 01/2024
1	Hepatitis 01/2024

Drug/Important Bio-Agent (IBA)

9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 03/2010
9	Rituximab (Mabthera)FDA Link 01/2020 - 05/2003
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2024 - 01/2007
5	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 07/2008
4	Lenalidomide (CC 5013)FDA Link 03/2024 - 04/2016
4	Calcineurin InhibitorsIBA 02/2024 - 10/2006
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010 - 12/2004
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 12/2007
3	Busulfan (Busulfex)FDA Link 01/2023 - 01/2005
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2020 - 01/2018
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2010
3	Bortezomib (Velcade)FDA Link 12/2019 - 10/2010
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019 - 10/2009
3	Immunosuppressive Agents (Immunosuppressants)IBA 10/2019 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 12/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 10/2010
2	Proteasome InhibitorsIBA 03/2024 - 12/2023
2	Immunomodulating AgentsIBA 03/2024 - 12/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2013
2	romiplostim FDA Link 12/2023 - 01/2021
2	AutoantibodiesIBA 02/2023 - 01/2022
2	fludarabineIBA 01/2023 - 10/2009
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 12/2007
2	Tyrosine Kinase InhibitorsIBA 02/2021 - 03/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2007
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 03/2010
2	Prednisone (Sone)FDA LinkGeneric 12/2019 - 03/2010
2	Methylprednisolone FDA LinkGeneric 10/2019 - 10/2008
2	RNA (Ribonucleic Acid)IBA 05/2019 - 01/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 02/2018 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 05/2003
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 10/2009
2	Valganciclovir FDA Link 07/2012 - 03/2009
1	carfilzomibIBA 03/2024
1	Asparaginase (Elspar)FDA Link 02/2024
1	AmmoniaIBA 02/2024
1	HLA-B Antigens (HLA-B)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	nasIBA 01/2024

Therapy/Procedure

31	Transplantation 02/2024 - 12/2004
30	Hematopoietic Stem Cell Transplantation 01/2024 - 11/2003
26	Therapeutics 12/2024 - 11/2003
24	Drug Therapy (Chemotherapy) 10/2021 - 04/2003
17	Stem Cell Transplantation 12/2023 - 11/2003
14	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2024 - 11/2003
8	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2016 - 04/2003
7	Cell Transplantation 11/2023 - 03/2012
4	Radiotherapy 04/2016 - 05/2003
3	Haploidentical Transplantation 02/2024 - 04/2013
1	Liver Transplantation 12/2024